REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medlex Sp. z o.o. (Poland)

Main Activities: Offices of Lawyers
Secondary Activities: Construction of Buildings | Merchant Wholesalers, Durable Goods | Motor Vehicle and Motor Vehicle Parts and Supplies Merchant Wholesalers | Motor Vehicle and Parts Dealers | Warehousing and Storage | Real Estate | Rental and Leasing Services | Office Administrative Services | Automotive Repair and Maintenance
Full name: Medlex Sp. z o.o. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Medlex Sp. z o.o. is a company based in Poland, with its head office in Otwock Wielki. The enterprise operates in the Offices of Lawyers industry. The enterprise was incorporated on July 26, 2019. Its’ total assets recorded a negative growth of 12.43%.

Headquarters
Ul. Wislana 32P
Otwock Wielki; Mazowieckie; Postal Code: 05-480

Contact Details: Purchase the Medlex Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medlex Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Medlex Sp. z o.o. report to view the information.
Incorporation Date:
July 26, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
91%
Company Performance
Financial values in the chart are available after Medlex Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total assets
-12.43%▼
Total equity
N/A

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo